CISATRACURIUM MYLAN (Alphapharm Pty Ltd)
Product name
CISATRACURIUM MYLAN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
211 (255 working days)
Active ingredients
cisatracurium besilate
Registration type
New generic medicine
Indication
CISATRACURIUM MYLAN (solution for injection) is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. It is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.